GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioVaxys Technology Corp (OTCPK:BVAXF) » Definitions » Dividends per Share

BioVaxys Technology (BioVaxys Technology) Dividends per Share : $0.00 (TTM As of Jul. 2023)


View and export this data going back to 2018. Start your Free Trial

What is BioVaxys Technology Dividends per Share?

BioVaxys Technology's dividends per share for the three months ended in Jul. 2023 was $0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jul. 2023 was $0.00. Its Dividend Payout Ratio for the three months ended in Jul. 2023 was 0.00. As of today, BioVaxys Technology's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.


BioVaxys Technology Dividends per Share Historical Data

The historical data trend for BioVaxys Technology's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioVaxys Technology Dividends per Share Chart

BioVaxys Technology Annual Data
Trend Oct18 Oct19 Oct20 Oct21 Oct22
Dividends per Share
- - - - -

BioVaxys Technology Quarterly Data
Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23
Dividends per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of BioVaxys Technology's Dividends per Share

For the Biotechnology subindustry, BioVaxys Technology's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioVaxys Technology's Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BioVaxys Technology's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where BioVaxys Technology's Dividend Yield % falls into.



BioVaxys Technology Dividends per Share Calculation

Dividends paid to per common share.


BioVaxys Technology  (OTCPK:BVAXF) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

BioVaxys Technology's Dividend Payout Ratio for the quarter that ended in Jul. 2023 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Jul. 2023 )/ EPS without NRI (Q: Jul. 2023 )
=0/ -0.002
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioVaxys Technology Dividends per Share Related Terms

Thank you for viewing the detailed overview of BioVaxys Technology's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


BioVaxys Technology (BioVaxys Technology) Business Description

Traded in Other Exchanges
Address
146 Thirtieth Street, Suite 100, Etobicoke, ON, CAN, M8W 3D4
BioVaxys Technology Corp is a clinical-stage biopharma company. The company develops antiviral and anticancer vaccine platforms to treat SARS-CoV-2 and other viral infections, as well as ovarian cancer and other solid tumor types.

BioVaxys Technology (BioVaxys Technology) Headlines